Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zilretta in Knee Osteoarthritis
NCT03895840Phase 4Completed
- Sponsor
- University of Kansas Medical Center
- Start
- Mar 2018
- Primary completion
- May 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of triamcinolone acetonide in knee osteoarthritis (OA), sponsored by University of Kansas Medical Center. Primary endpoints: 30 Second Chair Standing Test at 12 weeks, 40m Fast Paced Walking Test at 12 weeks and 1 more. Started Mar 2018; status: completed.
02
Drugs
triamcinolone acetonide
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03895840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03895840.